Pharma Times

AUGUST 7, 2020

Scientists from the University of Oxford say the drug is being ‘discarded prematurely’

170

170

NY Times

AUGUST 6, 2020

A letter signed by nearly 400 health experts asked the agency to use its vaccine advisory panel when reviewing data on coronavirus trials.

Vaccines 145

Vaccines 145

pharmaphorum

AUGUST 4, 2020

New research looks at the factors that speed up and slow down HTA appraisals for rare disease medicines across Europe. Rare diseases drugs have always faced challenges when it comes to HTA approvals, even as governments bring in more regulatory policies that make their path through assessment easier. Several factors make it difficult for HTA bodies often to assess orphan drugs, including a lack of robust trial data due to difficulties in finding patients, the absence of randomised controlled tri

Labelling 122

Labelling 122

Outsourcing Pharma

AUGUST 3, 2020

Neurasic Therapeutics is borne from a collaborative effort intended to advance development of opioid-alternative pain relief.

101

101

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

Pharma Times

AUGUST 3, 2020

Low-dose and high-dose Cosentyx is effective in rapidly improving skin symptoms and quality of life

146

146

NY Times

AUGUST 5, 2020

How much freedom should front-line clinicians have in treating Covid-19 patients with unproven drugs? The question opened up a civil war in some hospitals.

Hospitals 111

Hospitals 111

Outsourcing Pharma

AUGUST 5, 2020

The bipartisan bill calls for an assessment of the countryâs pharma supply chain, including potential vulnerabilities and impact of foreign manufacturing.

98

98

Pharma Times

AUGUST 3, 2020

Subcutaneous formulation of Darzalex in combination with pomalidomide and dexamethasone meets primary endpoint

145

145

NY Times

AUGUST 4, 2020

Getting medication long meant seeing a licensed provider. Now a strategy for evading Covid-19 makes treatment available via the web.

98

98

pharmaphorum

AUGUST 5, 2020

The UK government has asked pharma companies to build a six-week stockpile of drugs and find alternative shipping routes to the congested Dover-Calais crossing as the country heads for Brexit at the end of the year. In a letter , Steve Oldfield, chief commercial officer at the Department of Health and Social Care, said the government is focused on preventing potential disruption to any categories of medical supplies.

111

111

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

Pharma Marketing Network

AUGUST 3, 2020

Recently, the Healthcare Businesswomen’s Association (HBA) held a webinar entitled, Virtual Best Practices: Clarity, Collaboration and Connecting , which dove into the topic of “Zoom fatigue,” a new, commonly used term defined by the draining feeling you experience after a day of long, unnecessary meetings. We are all facing new challenges in the rapidly changing work environment.

Communication 94

Communication 94

Pharma Times

AUGUST 5, 2020

Roche, AstraZeneca, Novo Nordisk and Sanofi all climbed index rankings

142

142

Outsourcing Pharma

AUGUST 6, 2020

A leader from the scientific software provider discusses the most challenging obstacles in the pharma supply chain, and solutions that can conquer them.

69

69

pharmaphorum

AUGUST 4, 2020

Shares in Redx Pharma were soaring this morning after it licensed its preclinical fibrotic disease drug RXC006 to AstraZeneca. The company’s shares were valued as high as 95p on the London Stock Exchange following the announcement, the highest they had been since 2015. AstraZeneca has bought an exclusive global licence to develop and market RXC006, a porcupine inhibitor for fibrotic diseases including idiopathic pulmonary fibrosis (IPF).

109

109

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

Pharma in Brief

AUGUST 5, 2020

Summary. On July 24, 2020, the Federal Court dismissed an application for judicial review brought by Natco Pharma (Canada) Inc. ( Natco ) in respect of a July 26, 2019 decision ( Decision ) by the Minister of Health ( Minister ). The Decision refused to accept Natco’s ANDS filing using Gilead Sciences Canada Inc.’s ( Gilead ) product DESCOVY as the Canadian Reference Product.

52

52

Pharma Times

AUGUST 4, 2020

Drug approved to treat major depressive disorder with acute suicidal ideation or behaviour

142

142

Outsourcing Pharma

AUGUST 6, 2020

The agency continues to provide resources for the life-sciences industry, approve tests, and take action against companies offering false treatments.

60

60

pharmaphorum

AUGUST 5, 2020

The UK digital mental health support platform Kooth has joined with five of the UK’s well known Instagram influencers to launch a campaign to help students deal with the pressures of exam results season. The campaign encourages the hundreds of thousands of students waiting to receive their exam results, to stay mentally strong and know they have access to support, if needed.

105

105

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Drug Patent Watch

AUGUST 4, 2020

I’ll be giving a talk on Finding and Evaluating Market Entry Opportunities for a Better ROI at the upcoming 13th Portfolio Management & Pipeline Optimization for Generics from September 30th…. The post Finding and Evaluating Market Entry Opportunities for a Better ROI appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Pharma Times

AUGUST 5, 2020

AZ will pay $17m in early milestone payments for the UK biotech’s fibrotic asset

137

137

Outsourcing Pharma

AUGUST 6, 2020

A leader from IBM Watson Health talks about how its advanced EDC solution is geared toward helping studies save precious time and conserve costs.

59

59

pharmaphorum

AUGUST 6, 2020

The FDA has approved GlaxoSmithKline’s multiple myeloma drug Blenrep, a first-in-class potential blockbuster that will be used in advanced disease. Blenrep (belantamab mafodotin) has been approved in patients who have received at least four therapies including an anti-CD38 such as Darzalex, a proteasome inhibitor and an immunomodulatory agent. This is an accelerated approval based on response data and GSK may need survival data from a larger trial to keep the drug on the market in the longer ter

Adverse Reactions 87

Adverse Reactions Packaging 87

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

Drug Channels

AUGUST 3, 2020

NASP 2020 Annual Meeting & Expo Virtual Experience. September 14-18, 2020 | Virtual Experience www.naspmeeting.com/registration. Utilizing innovation and cutting-edge technology, the National Association of Specialty Pharmacy (NASP) is hosting its 2020 Annual Meeting & Expo, September 14-18, as a full-scale virtual conference experience that includes all that attendees have come to expect and love from the live event.

Specialty Pharmacies 52

Specialty Pharmacies Hospitals 52

Pharma Times

AUGUST 4, 2020

Agreement will utilise Oxford Biomedica's LentiVector platform

137

137

Outsourcing Pharma

AUGUST 5, 2020

Representatives from the CDMO offer perspective on problems plaguing the global pharma supply chain, and possible ways to improve them.

59

59

pharmaphorum

AUGUST 5, 2020

As populations age, multimorbidity becomes an increasingly pertinent issue for healthcare systems. A new action group from the ABPI seeks to bring the NHS, academia and industry together to find new ways to address the problem. The Association’s Dr Sheuli Porkess and Professor Janet Lord from the University of Birmingham tell us more. Multimorbidity is an increasing issue for healthcare and the NHS.

Hospitals 80

Hospitals Labelling Diabetes Drug Development 80

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

Drug Channels

AUGUST 7, 2020

Today’s guest post comes from Rob Brown, VP/GM of RxCrossroads by McKesson Program Pharmacy. Rob reviews how COVID-19 is changing patient access and adherence to specialty therapies. He then describes specific RxCrossroads’ program changes that are helping patients and providers remain on therapy and navigate this challenging environment. To learn more, visit www.McKesson.com/RxCrossroads.

40

40

Pharma Times

AUGUST 6, 2020

Draft guidance says some commonly used drug treatments should be avoided

136

136

Outsourcing Pharma

AUGUST 5, 2020

Initial information from the life-sciences specialistâs pilot program shows potential pathways to solving common pharma supply chain challenges.

59

59

pharmaphorum

AUGUST 5, 2020

Bringing clinical trials to patients – rather than the reverse – could be the key to improving recruitment into studies and making them faster, cheaper and more likely to succeed, according to one clinical research organisation (CRO). There’s already plenty of support from regulators for virtual or ‘decentralised’ trials, including from former FDA Commissioner Scott Gottlieb who said last year that the agency was encouraging adoption of this approach to make trials more “agile and efficient”, as

75

75

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management